Dr. Kathrin Davari

Dr. Kathrin Davari is an experienced professional in the biotechnology industry, currently serving as Vice President of Portfolio Management and Strategy and Vice President of TCR Discovery at Medigene AG since July 2017. With a strong background in project management and pre-clinical development of cellular immunotherapies, Dr. Davari has effectively led multiple high-performance R&D teams and facilitated cross-departmental resource planning. Previous roles include Director and Senior Scientist/Lab Head at HelmholtzZentrum München, where Dr. Davari demonstrated leadership in collaborative international projects and gained extensive experience in both industrial and academic research. Dr. Davari holds a Doctorate in Immunologie from Friedrich Schiller University Jena and a Diplom in Molecular Biology from Ludwig-Maximilians-Universität München.